Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/joim.13198 http://scihub22266oqcxt.onion/10.1111/joim.13198 33107999!7839714!33107999     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Intern+Med 2020 ; 288 (6): 682-688 Nephropedia Template TP {{tp|p=33107999|t=2020. On the relationship between BCG coverage and national COVID-19 outcome: could heterologous herd immunity explain why some countries are better off?|pdf=|usr=}}{{33107999}} gab.com Text On the relationship between BCG coverage and national COVID-19 outcome: could heterologous herd immunity explain why some countries are better off JO: J Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=33107999 #FOAvip The COVID-19 pandemic has affected most parts of the global society since its emergence, and the scientific community has been challenged with questions urgently demanding answers. One of the early hypotheses on COVID-19 outcome was that some protection could be offered by the tuberculosis vaccine (BCG), and several clinical studies were initiated along with the emergence of numerous observational studies on the relationship between BCG and COVID-19 severity. In the present work, I demonstrate a strong correlation between the number of years that countries implemented BCG vaccination plans and age-standardized mortality rates during the first months of the pandemic in Europe. Further analyses of age groups in two European countries with comparably few confounding factors and easily identifiable groups of BCG-vaccinated and non-vaccinated subgroups suggest a population-level effect of BCG on national outcomes of COVID-19. This phenomenon of 'heterologous herd immunity' deserves further investigation, both in epidemiological and experimental studies. Twit Text FOAVip On the relationship between BCG coverage and national COVID-19 outcome: could heterologous herd immunity explain why some countries are better off ????J Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=33107999 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33107999 #FOAvip English Wikipedia <ref>{{Cite pmid|33107999}}</ref> On the relationship between BCG coverage and national COVID-19 outcome: could heterologous herd immunity explain why some countries are better off? #MMPMID33107999 Lerm M J Intern Med 2020[Dec]; 288 (6): 682-688 PMID33107999show ga The COVID-19 pandemic has affected most parts of the global society since its emergence, and the scientific community has been challenged with questions urgently demanding answers. One of the early hypotheses on COVID-19 outcome was that some protection could be offered by the tuberculosis vaccine (BCG), and several clinical studies were initiated along with the emergence of numerous observational studies on the relationship between BCG and COVID-19 severity. In the present work, I demonstrate a strong correlation between the number of years that countries implemented BCG vaccination plans and age-standardized mortality rates during the first months of the pandemic in Europe. Further analyses of age groups in two European countries with comparably few confounding factors and easily identifiable groups of BCG-vaccinated and non-vaccinated subgroups suggest a population-level effect of BCG on national outcomes of COVID-19. This phenomenon of 'heterologous herd immunity' deserves further investigation, both in epidemiological and experimental studies. |*Immunity, Herd[MESH] |*Immunization Programs[MESH] |BCG Vaccine/*administration & dosage[MESH] |COVID-19/*prevention & control[MESH] |Confounding Factors, Epidemiologic[MESH] |Europe[MESH] |Humans[MESH] |Mortality[MESH]On the relationship between BCG coverage and national COVID-19 outcome(epmc).pdf DeepDyve Pubget Overpricing